Calithera Biosciences
Utility Patents

Last updated:

List of all Calithera Biosciences patents 21 in total

Status Patent
Grant
Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide External link
Filling date: 7 Nov 2025 Issue date: 28 Jun 2022
Grant
Utility: Solid state forms of fused heteroaromatic pyrrolidinones External link
Filling date: 7 Nov 2025 Issue date: 7 Jun 2022
Grant
Utility: Arginase inhibitor combination therapies External link
Filling date: 7 Nov 2025 Issue date: 5 Apr 2022
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 28 Dec 2021
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 16 Nov 2021
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 3 Aug 2021
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 15 Jun 2021
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 1 Jun 2021
Grant
Utility: Combination therapy with glutaminase inhibitors and immuno-oncology agents External link
Filling date: 7 Nov 2025 Issue date: 9 Mar 2021
Grant
Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide External link
Filling date: 7 Nov 2025 Issue date: 2 Feb 2021
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 2 Feb 2021
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 1 Dec 2020
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 24 Nov 2020
Grant
Utility: Heterocyclic glutaminase inhibitors External link
Filling date: 7 Nov 2025 Issue date: 6 Oct 2020
Grant
Utility: Crystal forms of glutaminase inhibitors External link
Filling date: 7 Nov 2025 Issue date: 9 Jun 2020
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 24 Mar 2020
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 25 Feb 2020
Grant
Utility: Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide External link
Filling date: 7 Nov 2025 Issue date: 3 Dec 2019
Grant
Utility: Ectonucleotidase inhibitors and methods of use thereof External link
Filling date: 7 Nov 2025 Issue date: 12 Nov 2019
Grant
Utility: Treatment of lung cancer with inhibitors of glutaminase External link
Filling date: 7 Nov 2025 Issue date: 15 Oct 2019
Grant
Utility: Compositions and methods for inhibiting arginase activity External link
Filling date: 7 Nov 2025 Issue date: 3 Sep 2019

Showing 1 to 21 of 21 patents.